GH Research to Present at ASCP Annual Meeting
Ticker: GHRS · Form: 6-K · Filed: May 21, 2025 · CIK: 1855129
| Field | Detail |
|---|---|
| Company | Gh Research PLC (GHRS) |
| Form Type | 6-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: conference, pipeline-update, presentation
TL;DR
GH Research presenting pipeline at ASCP meeting May 27-30.
AI Summary
GH Research PLC announced on May 21, 2025, that it will attend the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting from May 27-30, 2025, in Scottsdale, Arizona. The company will present posters during the meeting, including one for the Pharmaceutical Pipeline Presentation session by Michael E. Thase.
Why It Matters
The presentation at the ASCP Annual Meeting provides GH Research PLC an opportunity to showcase its pharmaceutical pipeline and research findings to key opinion leaders and potential partners in the clinical psychopharmacology field.
Risk Assessment
Risk Level: low — This filing is an informational report about conference attendance and presentations, with no new financial or operational disclosures that would significantly alter risk.
Key Players & Entities
- GH Research PLC (company) — Registrant
- American Society of Clinical Psychopharmacology (company) — Conference Organizer
- ASCP (company) — Conference Organizer Abbreviation
- May 27-30, 2025 (date) — Conference Dates
- Scottsdale, Arizona (location) — Conference Location
- Michael E. Thase (person) — Presenter
FAQ
What is the purpose of GH Research PLC's filing on May 21, 2025?
The purpose of the filing is to report that GH Research PLC will attend and present at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting from May 27-30, 2025.
Where and when will the ASCP Annual Meeting take place?
The ASCP Annual Meeting is scheduled to take place from May 27-30, 2025, in Scottsdale, Arizona.
Who will present a poster during the Pharmaceutical Pipeline Presentation session?
Michael E. Thase will present a poster during the Pharmaceutical Pipeline Presentation session.
What type of report is GH Research PLC filing?
GH Research PLC is filing a Form 6-K, which is a Report of Foreign Private Issuer.
Does GH Research PLC file annual reports under Form 20-F or Form 40-F?
GH Research PLC indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 21, 2025 by Michael E. Thase regarding GH Research PLC (GHRS).